{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:05:10Z","timestamp":1784192710286,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002839"],"award-info":[{"award-number":["82002839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Training Program for Emerging Clinical Scientists at Shanghai Children's Hospital","award":["2024QK04"],"award-info":[{"award-number":["2024QK04"]}]},{"name":"State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Medical University Cancer Institute & Hospital","award":["QZKF24-4"],"award-info":[{"award-number":["QZKF24-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00945-5","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:13:15Z","timestamp":1778699595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["H2S induces apoptosis of tumors with high IDO1 expression via NR4A1-BCL-2 and SOCS3 pathways"],"prefix":"10.1186","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-3219","authenticated-orcid":false,"given":"Zhen Ning Tony","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-922X","authenticated-orcid":false,"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"1","key":"945_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2017.7058","volume":"31","author":"X Cao","year":"2019","unstructured":"Cao X, Ding L, Xie Z-Z, Yang Y, Whiteman M, Moore PK, et\u00a0al. A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer? Antioxid Redox Signal. 2019;31(1):1\u201338.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"945_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113389","volume":"27","author":"S Khattak","year":"2022","unstructured":"Khattak S, Rauf MA, Khan NH, Zhang Q-Q, Chen H-J, Muhammad P, et\u00a0al. Hydrogen sulfide biology and its role in cancer. Molecules. 2022;27(11):3389.","journal-title":"Molecules"},{"issue":"51","key":"945_CR3","doi-asserted-by":"publisher","first-page":"21972","DOI":"10.1073\/pnas.0908047106","volume":"106","author":"A Papapetropoulos","year":"2009","unstructured":"Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, et\u00a0al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA. 2009;106(51):21972\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"30","key":"945_CR4","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1073\/pnas.1306241110","volume":"110","author":"C Szabo","year":"2013","unstructured":"Szabo C, Coletta C, Chao C, M\u00f3dis K, Szczesny B, Papapetropoulos A, et\u00a0al. Tumor-derived hydrogen sulfide, produced by cystathionine-\u03b2-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci USA. 2013;110(30):12474\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"945_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/odi.12223","volume":"21","author":"Z Ma","year":"2015","unstructured":"Ma Z, Bi Q, Wang Y. Hydrogen sulfide accelerates cell cycle progression in oral squamous cell carcinoma cell lines. Oral Dis. 2015;21(2):156\u201362.","journal-title":"Oral Dis"},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.niox.2015.08.004","volume":"50","author":"D Wu","year":"2015","unstructured":"Wu D, Si W, Wang M, Lv S, Ji A, Li Y. Hydrogen sulfide in cancer: friend or foe? Nitric Oxide. 2015;50:38\u201345.","journal-title":"Nitric Oxide"},{"issue":"5","key":"945_CR7","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3892\/ijo.2015.2914","volume":"46","author":"Y Zhen","year":"2015","unstructured":"Zhen Y, Pan W, Hu F, Wu H, Feng J, Zhang Y, et\u00a0al. Exogenous hydrogen sulfide exerts proliferation\/anti-apoptosis\/angiogenesis\/migration effects via amplifying the activation of NF-\u03baB pathway in PLC\/PRF\/5 hepatoma cells. Int J Oncol. 2015;46(5):2194\u2013204.","journal-title":"Int J Oncol"},{"key":"945_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2019.02.011","volume":"87","author":"I Szadvari","year":"2019","unstructured":"Szadvari I, Hudecova S, Chovancova B, Matuskova M, Cholujova D, Lencesova L, et\u00a0al. Sodium\/calcium exchanger is involved in apoptosis induced by H2S in tumor cells through decreased levels of intracellular pH. Nitric Oxide. 2019;87:1\u20139.","journal-title":"Nitric Oxide"},{"issue":"1","key":"945_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/pcmr.12312","volume":"28","author":"E Panza","year":"2015","unstructured":"Panza E, De Cicco P, Armogida C, Scognamiglio G, Gigantino V, Botti G, et\u00a0al. Role of the cystathionine \u03b3 lyase\/hydrogen sulfide pathway in human melanoma progression. Pigment Cell Melanoma Res. 2015;28(1):61\u201372.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"945_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3892\/ijo.2014.2305","volume":"44","author":"S Lu","year":"2014","unstructured":"Lu S, Gao Y, Huang X, Wang X. GYY4137, a hydrogen sulfide (H\u2082S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway. Int J Oncol. 2014;44(4):1259\u201367.","journal-title":"Int J Oncol"},{"key":"945_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1083-5","author":"D Yang","year":"2019","unstructured":"Yang D, Li T, Li Y, Zhang S, Li W, Liang H, et\u00a0al. H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma. J Exp Clin Cancer Res. 2019. https:\/\/doi.org\/10.1186\/s13046-019-1083-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"945_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/cmi.2017.143","volume":"15","author":"L Zhai","year":"2018","unstructured":"Zhai L, Ladomersky E, Lenzen A, Nguyen B, Patel R, Lauing KL, et\u00a0al. IDO1 in cancer: a Gemini of immune checkpoints. Cell Mol Immunol. 2018;15(5):447\u201357.","journal-title":"Cell Mol Immunol"},{"issue":"20","key":"945_CR13","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1111\/febs.16086","volume":"289","author":"MT Pallotta","year":"2022","unstructured":"Pallotta MT, Rossini S, Suvieri C, Coletti A, Orabona C, Macchiarulo A, et\u00a0al. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. FEBS J. 2022;289(20):6099\u2013118.","journal-title":"FEBS J"},{"key":"945_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2147\/OTT.S288692","volume":"14","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Gan G, Gao X, Luo Q, Chen F. Targeting the IDO-BCL2A1-cytochrome c pathway promotes apoptosis in oral squamous cell carcinoma. OncoTargets Ther. 2021;14:1673\u201387.","journal-title":"OncoTargets Ther"},{"key":"945_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05021-2","author":"C Sun","year":"2022","unstructured":"Sun C, Li M, Zhang L, Sun F, Chen H, Xu Y, et\u00a0al. IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma. Cell Death Dis. 2022. https:\/\/doi.org\/10.1038\/s41419-022-05021-2.","journal-title":"Cell Death Dis"},{"key":"945_CR16","doi-asserted-by":"crossref","unstructured":"Liu X, Zhou W, Zhang X, Ding Y, Du Q, Hu R. 1\u2010L\u2010MT, an IDO inhibitor, prevented colitis\u2010associated cancer by induc ing CDC20 inhibition\u2010mediated mitotic death of colon cancer cells. Int J Cancer. 143(6):1516\u201329.","DOI":"10.1002\/ijc.31417"},{"issue":"2","key":"945_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1053\/j.gastro.2013.05.002","volume":"145","author":"AI Thaker","year":"2013","unstructured":"Thaker AI, Rao MS, Bishnupuri KS, Kerr TA, Foster L, Marinshaw JM, et\u00a0al. IDO1 metabolites activate \u03b2-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. Gastroenterology. 2013;145(2):416-425.e411-414.","journal-title":"Gastroenterology"},{"issue":"16\u201318","key":"945_CR18","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/ars.2021.0215","volume":"37","author":"R Ren","year":"2022","unstructured":"Ren R, Fang Y, Sherchan P, Lu Q, Lenahan C, Zhang JH, et\u00a0al. Kynurenine\/aryl hydrocarbon receptor modulates mitochondria-mediated oxidative stress and neuronal apoptosis in experimental intracerebral hemorrhage. Antioxid Redox Signal. 2022;37(16\u201318):1111\u201329.","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"945_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ni.2077","volume":"12","author":"MT Pallotta","year":"2011","unstructured":"Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, et\u00a0al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12(9):870\u20138.","journal-title":"Nat Immunol"},{"issue":"1","key":"945_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jcmm.12954","volume":"21","author":"E Albini","year":"2017","unstructured":"Albini E, Rosini V, Gargaro M, Mondanelli G, Belladonna ML, Pallotta MT, et\u00a0al. Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. J Cell Mol Med. 2017;21(1):165\u201376.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"945_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/cmdc.202000116","volume":"15","author":"A Mammoli","year":"2020","unstructured":"Mammoli A, Coletti A, Ballarotto M, Riccio A, Carotti A, Grohmann U, et\u00a0al. New insights from crystallographic data: diversity of structural motifs and molecular recognition properties between groups of IDO1 structures. ChemMedChem. 2020;15(10):891\u20139.","journal-title":"ChemMedChem"},{"issue":"24","key":"945_CR22","doi-asserted-by":"publisher","first-page":"17690","DOI":"10.1021\/acs.jmedchem.1c01665","volume":"64","author":"UF Rohrig","year":"2021","unstructured":"Rohrig UF, Michielin O, Zoete V. Structure and plasticity of indoleamine 2,3-dioxygenase 1 (IDO1). J Med Chem. 2021;64(24):17690\u2013705.","journal-title":"J Med Chem"},{"issue":"8","key":"945_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s10585-009-9290-7","volume":"26","author":"H Urakawa","year":"2009","unstructured":"Urakawa H, Nishida Y, Nakashima H, Shimoyama Y, Nakamura S, Ishiguro N. Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma. Clin Exp Metastasis. 2009;26(8):1005\u201312.","journal-title":"Clin Exp Metastasis"},{"key":"945_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.imlet.2015.11.012","volume":"169","author":"A Ben-Haj-Ayed","year":"2016","unstructured":"Ben-Haj-Ayed A, Moussa A, Ghedira R, Gabbouj S, Miled S, Bouzid N, et\u00a0al. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma. Immunol Lett. 2016;169:23\u201332.","journal-title":"Immunol Lett"},{"issue":"1","key":"945_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-021-01847-4","volume":"40","author":"Y Yao","year":"2021","unstructured":"Yao Y, Liang H, Fang X, Zhang S, Xing Z, Shi L, et\u00a0al. What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past. J Exp Clin Cancer Res. 2021;40(1):60.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9\u201310","key":"945_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.18071\/isz.76.0339","volume":"76","author":"M Kaya","year":"2023","unstructured":"Kaya M, Aksoy A, Artas G, Kaplan M. Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors. Ideggyogy Sz. 2023;76(9\u201310):339\u201347.","journal-title":"Ideggyogy Sz"},{"issue":"5","key":"945_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","volume":"22","author":"DH Munn","year":"2005","unstructured":"Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, et\u00a0al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22(5):633\u201342.","journal-title":"Immunity"},{"issue":"9","key":"945_CR28","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4161\/onci.21716","volume":"1","author":"R Metz","year":"2012","unstructured":"Metz R, Rust S, Duhadaway JB, Mautino MR, Munn DH, Vahanian NN, et\u00a0al. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: a novel IDO effector pathway targeted by D-1-methyl-tryptophan. Oncoimmunology. 2012;1(9):1460\u20138.","journal-title":"Oncoimmunology"},{"issue":"1","key":"945_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","volume":"11","author":"M Liu","year":"2018","unstructured":"Liu M, Wang X, Wang L, Ma X, Gong Z, Zhang S, et\u00a0al. Targeting the IDO1 pathway in cancer: from bench to bedside. J Hematol Oncol. 2018;11(1):100.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"945_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","volume":"39","author":"JE Cheong","year":"2018","unstructured":"Cheong JE, Sun L. Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy\u2014Challenges and opportunities. Trends Pharmacol Sci. 2018;39(3):307\u201325.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"945_CR31","first-page":"834","volume":"18","author":"C Orabona","year":"2012","unstructured":"Orabona C, Pallotta MT, Grohmann U. Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase. Mole Med (Cambridge, Mass). 2012;18(1):834\u201342.","journal-title":"Mole Med (Cambridge, Mass)"},{"issue":"52","key":"945_CR32","doi-asserted-by":"publisher","first-page":"20828","DOI":"10.1073\/pnas.0810278105","volume":"105","author":"C Orabona","year":"2008","unstructured":"Orabona C, Pallotta MT, Volpi C, Fallarino F, Vacca C, Bianchi R, et\u00a0al. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc Natl Acad Sci USA. 2008;105(52):20828\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"945_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1134551","volume":"14","author":"E Panfili","year":"2023","unstructured":"Panfili E, Mondanelli G, Orabona C, Gargaro M, Volpi C, Belladonna ML, et\u00a0al. The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1. Front Immunol. 2023;14:1134551.","journal-title":"Front Immunol"},{"key":"945_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070870","author":"Z Xing","year":"2024","unstructured":"Xing Z, Li X, He ZNT, Fang X, Liang H, Kuang C, et\u00a0al. IDO1 inhibitor RY103 suppresses Trp-GCN2-mediated angiogenesis and counters immunosuppression in glioblastoma. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16070870.","journal-title":"Pharmaceutics"},{"issue":"5","key":"945_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.555","volume":"5","author":"H Liang","year":"2024","unstructured":"Liang H, Zhan J, Chen Y, Xing Z, He ZNT, Liu Y, et\u00a0al. Tryptophan deficiency induced by indoleamine 2,3-dioxygenase 1 results in glucose transporter 1-dependent promotion of aerobic glycolysis in pancreatic cancer. MedComm. 2024;5(5):e555.","journal-title":"MedComm"},{"issue":"6","key":"945_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","volume":"10","author":"E Gottlieb","year":"2003","unstructured":"Gottlieb E, Armour SM, Harris MH, Thompson CB. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 2003;10(6):709\u201317.","journal-title":"Cell Death Differ"},{"issue":"3","key":"945_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","volume":"10","author":"CFA Warren","year":"2019","unstructured":"Warren CFA, Wong-Brown MW, Bowden NA. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis. 2019;10(3):177.","journal-title":"Cell Death Dis"},{"issue":"2","key":"945_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1158\/1541-7786.MCR-20-0707","volume":"19","author":"S Safe","year":"2021","unstructured":"Safe S, Karki K. The paradoxical roles of orphan nuclear receptor 4A (NR4A) in cancer. Mol Cancer Res. 2021;19(2):180\u201391.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"945_CR39","doi-asserted-by":"publisher","first-page":"E62","DOI":"10.1073\/pnas.1711373114","volume":"115","author":"US Gautam","year":"2018","unstructured":"Gautam US, Foreman TW, Bucsan AN, Veatch AV, Alvarez X, Adekambi T, et\u00a0al. In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 2018;115(1):E62\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"945_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1517\/14728222.11.1.69","volume":"11","author":"X-k Zhang","year":"2006","unstructured":"Zhang X-k. Targeting Nur77 translocation. Expert Opin Ther Targets. 2006;11(1):69\u201379.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"945_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14331-y","volume":"11","author":"MD Carpenter","year":"2020","unstructured":"Carpenter MD, Hu Q, Bond AM, Lombroso SI, Czarnecki KS, Lim CJ, et\u00a0al. Nr4a1 suppresses cocaine-induced behavior via epigenetic regulation of homeostatic target genes. Nat Commun. 2020;11(1):504.","journal-title":"Nat Commun"},{"issue":"4","key":"945_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1158\/0008-5472.CAN-22-1837","volume":"83","author":"T Yue","year":"2023","unstructured":"Yue T, Li J, Zhu J, Zuo S, Wang X, Liu Y, et\u00a0al. Hydrogen Sulfide creates a favorable immune microenvironment for colon cancer. Cancer Res. 2023;83(4):595\u2013612.","journal-title":"Cancer Res"},{"key":"945_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101573","volume":"75","author":"A Salminen","year":"2022","unstructured":"Salminen A. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev. 2022;75:101573.","journal-title":"Ageing Res Rev"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00945-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00945-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00945-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:32:39Z","timestamp":1784190759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00945-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00945-5","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experiments on mice were approved by the Animal Ethics Committee of Fudan University (approval no. JS-006, 4 March 2019) and performed in compliance with ARRIVE and ICLAS guidelines. Tumor sizes in this study did not exceed 2000 mm\n                      3\n                      , the maximum size permitted by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"115"}}